THRX NASDAQ
Theseus Pharmaceuticals, Inc.
1W: +0.0%
1M: +1.5%
3M: +20.5%
1Y: -59.9%
$4.07
Last traded 2024-02-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$438K
-21800.0% ▼
Operating Income
-$54M
-97.9% ▼
Net Income
-$47M
-72.4% ▼
EPS (Diluted)
$-1.22
-60.5% ▼
EBITDA
-$54M
-97.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2K | $2K | $2K | $438K |
| Gross Profit | -$2K | -$2K | -$2K | -$438K |
| Gross Margin | — | — | — | — |
| R&D Expenses | $4M | $6M | $18M | $36M |
| SG&A Expenses | $818K | $878K | $9M | $18M |
| Operating Expenses | $5M | $7M | $27M | $54M |
| Operating Income | -$5M | -$7M | -$27M | -$54M |
| Operating Margin | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 |
| Income Before Tax | -$7M | -$12M | -$27M | -$51M |
| Tax Expense | $0 | $0 | $0 | -$4M |
| Net Income | -$7M | -$12M | -$27M | -$47M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $-0.28 | $-0.47 | $-0.76 | $-1.22 |
| EBITDA | -$5M | -$7M | -$27M | -$54M |
| Shares Outstanding | 25M | 25M | 36M | 38M |